Medline (MDLN) Signs First Prime Vendor Agreement with Mohawk Medbuy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
Medline Inc (MDLN) PT Lowered to $45 at Barclays, 'Material input costs are the biggest swing factor in F26'
May 29, 2026 5:22 AM EDTBarclays analyst Glen Santangelo lowered the price target on Medline Inc (NASDAQ: MDLN) to $45.00 (from $50.00) while maintaining a Overweight rating.
The analyst comments "Material input costs are the biggest swing factor in F26. Management quantified fuel as ~50bps of total COGS, which helps frame the impact of recent oil price volatility. We estimate that with oil prices up 50% YTD, this could represent an incremental ~25bp margin headwind from... More
Medline completes $2.68 billion secondary stock offering
May 28, 2026 4:30 PM EDTMedline Inc. (NASDAQ: MDLN) completed a secondary offering of 72.6 million shares of Class A common stock at $37.00 per share, the company announced. The offering was conducted by selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a subsidiary of the Abu Dhabi Investment Authority.
... More